Concepedia

Ashwini M. Londhe

AM

Statistics

Publications

11

Citations

542

H-Index

11

Active since

2014

Affiliations

Korea University of Science and Technology(Current)

Convergence Research Center for Diagnosis Treatment and Care System of Dementia

Korea Institute of Science and Technology

Bio-Medical Science (South Korea)

Kyung Hee University

Ashwini M. Londhe is an author at Korea University of Science and Technology specializing in life sciences, pharmacology, and drug discovery.

ORCID

Publications per year

2014–2021

11

Publications

11

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

Jong‐Hyun Park, Yeon Ha Ju, Ji Won Choi et al. · Science Advances · 2019 · 204 citations · Full text

, , +17

Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model

Siwon Kim, Ambily Nath Indu Viswanath, Jong‐Hyun Park et al. · Neuropharmacology · 2020 · 107 citations

, , +17

Investigation of Molecular Details of Keap1-Nrf2 Inhibitors Using Molecular Dynamics and Umbrella Sampling Techniques

Ashwini M. Londhe, Changdev G. Gadhe, Sang Min Lim et al. · Molecules · 2019 · 65 citations · Full text

, , +17

Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders

Ahmed Karam Farag, Ahmed Elkamhawy, Ashwini M. Londhe et al. · European Journal of Medicinal Chemistry · 2017 · 33 citations · Full text

, , +14

Discovery of<i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B

Ahmed Elkamhawy, Sora Paik, Hyeon Jeong Kim et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2020 · 30 citations · Full text

, , +17

1–5 of 11